The influence of age on propofol pharmacodynamics.
T W Schnider, C F Minto, S L Shafer...
https://pubmed.ncbi.nlm.nih.gov/10360845Actively Recruiting
Led by Hacettepe University · Updated on 2025-11-20
84
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are comparing two pharmacokinetic models, Eleveld and Schnider, for administering propofol sedation in mechanically ventilated patients in the intensive care unit (ICU). This observational study aims to assess which model better controls sedation depth, maintains hemodynamic stability, and supports faster recovery. The study uses sedation scales and monitoring tools like the Bispectral Index (BIS) and Riker Sedation-Agitation Scale to evaluate patient responses and safety. Participants will receive propofol through a target-controlled infusion (TCI) system guided by either the Eleveld or Schnider model. Sedation will be adjusted to maintain a Riker score between 3 and 4 and a BIS value between 60 and 80. Researchers will record hemodynamic variables, total propofol dosage, awakening time, and incidence of delirium after sedation withdrawal. No other sedatives or hypnotics will be used during sedation. During the study, patients will be monitored for sedation accuracy using BIS values for up to 72 hours. Assessments will include the proportion of time patients remain within the target sedation range. Data such as medical history, laboratory tests, and sedation depth will be collected and analyzed. The study will help identify the most reliable model for safe and effective sedation in ICU settings, with continuous monitoring of patient safety and sedation effects throughout the sedation period.
CONDITIONS
A Comparative Study of Eleveld and Schnider Pharmacokinetic Models for Target-Controlled Infusion of Propofol in Sedation of Mechanically Ventilated ICU Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 72 hours
Participants receive sedation with propofol administered via a target-controlled infusion (TCI) system guided by either the Eleveld or Schnider pharmacokinetic model. Sedation depth is carefully titrated and monitored to maintain target sedation levels.
Continuous monitoring during sedation period
Duration - Short-term post-sedation monitoring
Participants are observed for awakening time, hemodynamic parameters, and incidence of delirium after sedation ends to assess recovery and safety.
Approximately 1 to 2 visits depending on recovery
Total: 1 location
1
Hacettepe University
Ankara, Turkey (Türkiye)
Actively Recruiting
D
DUYGU OZDEMIR SIMSEK, MD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
T W Schnider, C F Minto, S L Shafer...
https://pubmed.ncbi.nlm.nih.gov/10360845